NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class i molecules

Journal of Immunology

Volumn 192, Issue 6, 2014, Pages 2602-2610

  Sleiman, Marwan ^a,b   Brons, Nicolaas H C ^a   Kaoma, Tony ^a   Dogu, Figen ^c   Villa Forte, Alexandra ^d   Lenoble, Patrick ^e   Hentges, François ^a   Kotsch, Katja ^f   Gadola, Stephan D ^g   Vilches, Carlos ^h   Zimmer, Jacques ^a  

^a Public Research Center for Health   (Luxembourg)

^b UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^c ANKARA UNIVERSITY   (Turkey)

^d LERNER RESEARCH INSTITUTE   (United States)

^e CENTRE HOSPITALIER DE MULHOUSE   (France)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g NOVARTIS PHARMA AG   (Switzerland)

^h HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL KILLER CELL RECEPTOR NKG2A;

ADULT; ARTICLE; CELL EXPANSION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TAP GENE;

ADULT; ANTIGENS, CD56; ANTIGENS, CD57; ANTIGENS, CD8; ATP-BINDING CASSETTE TRANSPORTERS; CELL DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MALE; MIDDLE AGED; MUTATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, KIR;

EID: 84897516795     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302843     Document Type: Article

References (32)

1. Caligiuri, M. A. 2008. Human natural killer cells. Blood 112: 461-469.
2. Held, W., M. Kijima, G. Angelov, and S. Bessoles. 2011. The function of natural killer cells: education, reminders and some good memories. Curr. Opin. Immunol. 23: 228-233.
3. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
4. Joncker, N. T., and D. H. Raulet. 2008. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol. Rev. 224: 85-97.
5. Jonsson, A. H., and W. M. Yokoyama. 2009. Natural killer cell tolerance licensing and other mechanisms. Adv. Immunol. 101: 27-79.
6. Ljunggren, H. G., and K. Kärre. 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11: 237-244.
7. Gadola, S. D., H. T. Moins-Teisserenc, J. Trowsdale, W. L. Gross, and V. Cerundolo. 2000. TAP deficiency syndrome. Clin. Exp. Immunol. 121: 173-178.
8. Zimmer, J., E. Andrès, L. Donato, D. Hanau, F. Hentges, and H. de la Salle. 2005. Clinical and immunological aspects of HLA class I deficiency. QJM 98: 719-727.
9. Zimmer, J., L. Donato, D. Hanau, J. P. Cazenave, M. M. Tongio, A. Moretta, and H. de la Salle. 1998. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J. Exp. Med. 187: 117-122.
10. Furukawa, H., T. Yabe, K. Watanabe, R. Miyamoto, A. Miki, T. Akaza, K. Tadokoro, S. Tohma, T. Inoue, K. Yamamoto, and T. Juji. 1999. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). Hum. Immunol. 60: 32-40.
11. Vitale, M., J. Zimmer, R. Castriconi, D. Hanau, L. Donato, C. Bottino, L. Moretta, H. de la Salle, and A. Moretta. 2002. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood 99: 1723-1729.
12. Schönberg, K., J. C. Fischer, G. Kögler, and M. Uhrberg. 2011. Neonatal NKcell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I. Blood 117: 5152-5156.
13. Schönberg, K., M. Sribar, J. Enczmann, J. C. Fischer, and M. Uhrberg. 2011. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 117: 98-107.
14. Andersson, S., C. Fauriat, J. A. Malmberg, H. G. Ljunggren, and K. J. Malmberg. 2009. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 114: 95-104.
15. Sternberg-Simon, M., P. Brodin, Y. Pickman, B. Ö nfelt, K. Kärre, K. J. Malmberg, P. Höglund, and R. Mehr. 2013. Natural killer cell inhibitory receptor expression in humans and mice: a closer look. Front. Immunol. 4: 65.
16. Béziat, V., L. L. Liu, J. A. Malmberg, M. A. Ivarsson, E. Sohlberg, A. T. Björklund, C. Retiére, E. Sverremark-Ekström, J. Traherne, P. Ljungman, et al. 2013. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121: 2678-2688.
17. Parissiadis, A., A. Dormoy, D. Fricker, D. Hanau, H. de la Salle, J. P. Cazenave, P. Lenoble, and L. Donato. 2005. Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiency. Br. J. Ophthalmol. 89: 1661-1662.
18. Doǧu, F., A. Ikincioǧullari, D. Fricker, G. Bozdoǧan, C. Aytekin, M. Ileri, T. Teziç, E. Babacan, and H. De La Salle. 2006. A novel mutation for TAP deficiency and its possible association with Toxoplasmosis. Parasitol. Int. 55: 219-222.
19. Caversaccio, M., H. M. Bonél, R. Carter, A. P. Williams, and S. D. Gadola. 2008. TAP deficiency syndrome: chronic rhinosinusitis and conductive hearing loss. Eur. Arch. Otorhinolaryngol. 265: 1289-1292.
20. Villa-Forte, A., H. de la Salle, D. Fricker, F. Hentges, and J. Zimmer. 2008. HLA class I deficiency syndrome mimicking Wegener's granulomatosis. Arthritis Rheum. 58: 2579-2582.
21. Björkström, N. K., P. Riese, F. Heuts, S. Andersson, C. Fauriat, M. A. Ivarsson, A. T. Björklund, M. Flodström-Tullberg, J. Michaëlsson, M. E. Rottenberg, et al. 2010. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116: 3853-3864.
22. Lopez-Vergés, S., J. M. Milush, S. Pandey, V. A. York, J. Arakawa-Hoyt, H. Pircher, P. J. Norris, D. F. Nixon, and L. L. Lanier. 2010. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116: 3865-3874.
23. Pyo, C. W., L. A. Guethlein, Q. Vu, R. Wang, L. Abi-Rached, P. J. Norman, S. G. Marsh, J. S. Miller, P. Parham, and D. E. Geraghty. 2010. Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS ONE 5: e15115.
24. Ljunggren, H. G., L. Van Kaer, H. L. Ploegh, and S. Tonegawa. 1994. Altered natural killer cell repertoire in Tap-1 mutant mice. Proc. Natl. Acad. Sci. USA 91: 6520-6524.
25. Furukawa, H., T. Yabe, T. Akaza, K. Tadokoro, S. Tohma, T. Inoue, K. Tokunaga, K. Yamamoto, D. E. Geraghty, and T. Juji. 1999. Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient. Tissue Antigens 53: 292-295.
26. Matamoros, N., J. Milà, M. Llano, A. Balas, J. L. Vicario, J. Pons, C. Crespí, N. Martinez, J. Iglesias-Alzueta, and M. López-Botet. 2001. Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency. Clin. Exp. Immunol. 125: 274-282.
27. Prod'homme, V., P. Tomasec, C. Cunningham, M. K. Lemberg, R. J. Stanton, B. P. McSharry, E. C. Wang, S. Cuff, B. Martoglio, A. J. Davison, et al. 2012. Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18. J. Immunol. 188: 2794-2804.
28. Lorente, E., S. Infantes, D. Abia, E. Barnea, I. Beer, R. García, F. Lasala, M. Jiménez, C. Mir, A. Morreale, et al. 2012. Aviral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule. J. Biol. Chem. 287: 34895-34903.
29. Sun, J., and P. B. Kavathas. 1997. Comparison of the roles of CD8 alpha alpha and CD8 alpha beta in interaction with MHC class I. J. Immunol. 159: 6077-6082.
30. Gao, G. F., B. E. Willcox, J. R. Wyer, J. M. Boulter, C. A. O'Callaghan, K. Maenaka, D. I. Stuart, E. Y. Jones, P. A. Van Der Merwe, J. I. Bell, and B. K. Jakobsen. 2000. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J. Biol. Chem. 275: 15232-15238.
31. Addison, E. G., J. North, I. Bakhsh, C. Marden, S. Haq, S. Al-Sarraj, R. Malayeri, R. G. Wickremasinghe, J. K. Davies, and M. W. Lowdell. 2005. Ligation of CD8alpha on human natural killer cells prevents activationinduced apoptosis and enhances cytolytic activity. Immunology 116: 354-361.
32. van Bergen, J., A. Thompson, M. van Pel, C. Retiére, D. Salvatori, D. H. Raulet, J. Trowsdale, and F. Koning. 2013. HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model. J. Immunol. 190: 2880-2885.